Skip to main content

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Verotta L (2003) Hypericum perforatum, a source of neuroactive lead structures. Current Topics Med Chem 3: 187–201

    Article  Google Scholar 

  2. Barnes J, Anderson LA, Phillipson JD (2001) St John’s Wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53: 583–600

    Article  PubMed  Google Scholar 

  3. Bombardelli E, Morazzoni P (1995) Hypericum perforatum. Fitoterapia 56: 43–68

    Google Scholar 

  4. Roth L (1990) Hypericum, Hypericin: Botanik, Inhaltsstoffe, Wirkung. Vol Ecomed, Landsberg/Lech

    Google Scholar 

  5. Buchner A (1830) Buchner’s Report. Pharm 34: 217

    Google Scholar 

  6. Siersch E (1927) Anatomie und Mikrochemie der Hypericum Drüsen (Chemie des Hypericins). Plants 3: 481

    Google Scholar 

  7. Brockmann H, Sanne W (1953) Pseudohypericin, ein neuer Hypericum-Farbstoff. Naturwissenschaften 40: 461

    Article  Google Scholar 

  8. Brockmann H (1957) Photodynamisch wirksame Pflanzenfarbstoffe. Fortschritt Chem Org Naturstoff 14: 141–177

    Google Scholar 

  9. Brockmann H, Franssen U, Spitzner D, Augustiniak H (1974) Zur Isolierung und Konstitution des Pseudohypericins. Tetrahedron Lett 15: 1991–1994

    Article  Google Scholar 

  10. Brockmann H, Haschad MN, Maier K, Pohl F (1939) Über das Hypericin, den photodynamisch wirksamen Farbstoff aus H. perforatum. Naturwissenschaften 27: 550

    Article  Google Scholar 

  11. Brockmann H, Kluge F (1951) Zur Synthese des Hypericins. Naturwissenschaften 38: 141

    Article  Google Scholar 

  12. Brockmann H, Sanne W (1957) Zur Kenntnis des Hypericins und Pseudohypericins. Chem. Berichte 90: 2480–2491

    Google Scholar 

  13. Brockmann H, Spitzner D (1975) Die Konstitution des Pseudohypericins. Tetrahedron Lett 16: 37–40

    Article  Google Scholar 

  14. Cameron D, Raverty WD (1976) Pseudohypericin and other phenanthroperlyne quinones. Aust J Chem 29: 1523–1533

    Google Scholar 

  15. Mathis C, Ourisson G (1963) Etude chimio-taxonomique du genre hypericum I. Repartition de l’hypericine. Phytochemistry 2: 157–171

    Google Scholar 

  16. Tolonen A, Uusitalo J, Hohtola A, Jalonen J (2002) Determination of naphthodianthones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. Rap Comm Mass Spectrom 16: 396–402

    Google Scholar 

  17. Freeman D, Kapinus E, Lavie D, Lavie G, Meruelo D, Mazur Y (1994) Acidic properties of hypericin and its octahydroxy analog in the ground and excited-states. J Chem Soc Chem Commun 7: 891–892

    Google Scholar 

  18. Lavie G, Mazur Y, Lavie D, Meruelo D (1995) The chemical and biological properties of Hypericin: a compound with a broad spectrum of biological activities. Med Res Rev 15: 111–119

    PubMed  Google Scholar 

  19. Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H (1984) Inhibition of monoamine oxydase by hypericin. Planta Med 50: 272–274

    PubMed  Google Scholar 

  20. Bladt S, Wagner H (1993) MAO-Hemmung durch Fraktionen und Inhaltsstoffen von Hypericum-Extrakt. Nervenheilkunde 12: 349–352

    Google Scholar 

  21. Yang KC, Prusti RK, Walker EB, Song P-S, Watanabe M, Furuya M (1986) Photodynamic action in Stentor coeruleus sensitized by endogenous pigment stentorin. Photochem Photobiol 43: 305–310

    PubMed  Google Scholar 

  22. Barnard DL, Huffman JH, Wood SG (1990) Characterization of the anti human cytomegalovirus (HCMV) activity of three anthraquinone compounds 30th Interscience Conference on Antimicrobial Agents and Chemotherapy,{ Atlanta, October 21–24}: 1093

    Google Scholar 

  23. Hudson JB, Lopez-Bazzocchi I, Towers GHN (1991) Antiviral activities of Hypericum Antivir Res 15: 101–112

    Google Scholar 

  24. Moraleda G, Wu TT, Jilbert AR, Aldrich CE, Condreay LD, Larsen SH, Tang JC, Colacino JM, Mason WS (1993) Inhibition of duck hepatitis B virus replication by hypericin. Antivir Res 20: 235–247

    PubMed  Google Scholar 

  25. Tang J, Colacino JM, Larsen SH, Spitze W (1990) Virucidal activity of Hypericum against enveloped and non-enveloped DNA and RNA virus. Antivir Res 13: 313–325

    PubMed  Google Scholar 

  26. Kraus GA, Pratt D, Tossberg J, Carpenter S (1990) Antiretroviral activity of synthetic hypericin and related analogs. Biochem Biophys Res Commun 172: 149–153

    PubMed  Google Scholar 

  27. Lavie G, Valentine F, Levin B, Mazur Y, Gallo G, Lavie D, Weiner D, Meruelo D (1989) Studies of the mechanism of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci USA 86: 5963–5967

    PubMed  Google Scholar 

  28. Lenard J, Rabson A, Vanderoef R (1993) Photodynamic inactivation of infectivity of human immunodeficiency virus and enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci USA 90: 158–162

    PubMed  Google Scholar 

  29. Lopez-Bazzocchi I, Hudson JB, Towers GHN (1991) Antiviral activity of the photoactive plant pigment hypericin. Photochem Photobiol 54: 95

    PubMed  Google Scholar 

  30. Meruelo D, Lavie G, Lavie D (1988) Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones Hypericin and Pseudohypericin. Proc Natl Acad Sci USA 85: 5230–5234

    PubMed  Google Scholar 

  31. Vlietinck AJ, De Bruyne T, Apers S, Pieters LA (1998) Plant-derived lead compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med 64: 97–109

    PubMed  Google Scholar 

  32. Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT (1999) Phase I studies of hypericin, the active compound in St. John’s Wort, as an antiretroviral agent in HIV-infected adults — AIDS clinical trials group protocols 150 and 258. Ann Intern Med 130: 510–514

    PubMed  Google Scholar 

  33. Vanhaelen M, Vanhaelen-Fastre R (1983) Quantitative determination of biologically active constituents in medicinal plant crude extracts by thin layer chromatography-densitometry. J Chromatogr 281: 263–271

    Google Scholar 

  34. Gurevich AI, Dobrynin VN, Kolosov MN, Popravko SA, Ryabova ID, Chernov BK, Derbents NA, Aizenman BE, Garaguly AD (1971) Hyperforin, an antibiotic from Hypericum perforatum L. Antibiotiki 16: 510–513

    PubMed  Google Scholar 

  35. Roz N, Mazur Y, Hirshfeld A, Rehavi M (2002) Inhibition of vesicular uptake of monoamines by hyperforin. Life Sciences 71: 2227–2237

    PubMed  Google Scholar 

  36. Bystrov NS, Chernov BK, Dobrynin VN, Kolosov MN (1975) Structure of hyperforin. Tetrahedron Lett 32: 2791–2794

    Google Scholar 

  37. Bystrov NS, Dobrynin VN, Kolosov MN, Chernov BK, Chervin, II, Yakovlev GI (1975) Structure of chromophoric moiety of hyperforin. Doklady Akademii Nauk Sssr 225: 1327–1328

    PubMed  Google Scholar 

  38. Bystrov NS, Dobrynin VN, Kolosov MN, Chernov BK, Chervin, II, Yakovlev GI (1976) Stoichiometry of antibiotic hyperforin. Doklady Akademii Nauk Sssr 226: 338–341

    PubMed  Google Scholar 

  39. Bystrov NS, Gupta SR, Dobrynin VN, Kolosov MN, Chernov BK, Chervin, II, Yakovlev GI, Aizenman BE, Derbentseva NA (1976) Structure of antibiotic hyperforin. Doklady Akademii Nauk Sssr 226: 88–90

    PubMed  Google Scholar 

  40. Brondz I, Greibrokk T, Groth P, Aasen AJ (1983) The absolute-configuration of hyperforin, an antibiotic from Hypericum-perforatum L, based on the crystal-structure determination of its para-bromobenzoate ester. Acta Chem Scan 37: 263–265

    Google Scholar 

  41. Maisenbacher P, Kovar KA (1992) Adhyperforin — a homolog of hyperforin from Hypericum-perforatum. Planta Med 58: 291–293

    Google Scholar 

  42. Shan MD, Hu LH, Chen ZL (2001) Three hyperforin analogues from Hypericum perforatum. J Nat Prod 64: 127–130

    PubMed  Google Scholar 

  43. Fuzzati N, Gabetta N, Strepponi I, Villa F (2001) High-performance liquid chromatography—electrospray ionization mass spectrometry and multiple mass spectrometry studies of hyperforin degradation products. J Chromatogr A 926: 187–198

    PubMed  Google Scholar 

  44. Trifunovic S, Vajs V, Macura S, Juranic N, Djarmati Z, Jankov R, Milosavljevic S (1998) Oxidation products of hyperforin from Hypericum perforatum. Phytochemistry 49: 1305–1310

    PubMed  Google Scholar 

  45. Vajs V, Vugdelija S, Trifunovic S, Karadzic I, Juranic N, Macura S, Milosavljevic S (2003) Further degradation products of hyperforin from Hypericum perforatum (St. John’s Wort). Fitoterapia 74: 439–444

    PubMed  Google Scholar 

  46. Verotta L, Appendino G, Belloro E, Jakupovic J, Bombardelli E (1999) Furohyperforin, a prenylated phloroglucinol from St. John’s Wort (Hypericum perforatum). J Nat Prod 62: 770–772

    PubMed  Google Scholar 

  47. Verotta L, Appendino G, Belloro E, Jakupovic J, Bombardelli E (2000) Hyperforin analogues from St. John’s Wort (Hypericum perforatum). J Nat Prod 63: 412–415

    PubMed  Google Scholar 

  48. Wolfender J-L, Verotta L, Fuzzati N, Strepponi I, Hostettmann K (2003) Structural investigations of isomeric oxidised forms of hyperforin by LC/NMR and LC/MSn. Phytochem Anal 14: 290–297

    PubMed  Google Scholar 

  49. Verotta L, Appendino G, Belloro E, Bianchi F, Sterner O, Lovati M, Bombardelli E (2002) Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety. J Nat Prod 65: 433–438

    PubMed  Google Scholar 

  50. Jerzmanowska Z (1937) Über das Hypericin, ein Glukosid von Hypericum perforatum L. Wiadomusci Farm 64: 527

    Google Scholar 

  51. Sprecher P, Casparis F, Müller HJ (1946) Untersuchungen über natürliche Flavonolglykoside. Pharm Acta Helvetiae 21: 341

    Google Scholar 

  52. Dorossiev I (1985) Determination of flavonoids in Hypericum perforatum. Pharmazie 40: 585–586

    PubMed  Google Scholar 

  53. Berghofer R, Holzl J (1987) Biflavonoids in Hypericum-perforatum.1. Isolation of I3,Ii8-Biapigenin. Planta Med 53: 216–217

    Google Scholar 

  54. Berghofer R, Holzl J (1989) Biflavonoids from Hypericum-perforatum L.2. Isolation of I3’,Ii8-Biapigenin (Amentoflavone) from Hypericum perforatum. Planta Med 55: 91

    Google Scholar 

  55. Demisch L, Hölzl J, Golnik B, Kaczmarczyk P (1989) Identification of selective MAO-type-A inhibitors in Hypericum perforatum L. (Hyperforat®). Pharmacopsychiatry 22: 194

    Google Scholar 

  56. Melzer R, Fricke U, Holzl J (1991) Vasoactive properties of procyanidins from Hypericum-perforatum-L in isolated porcine coronary-arteries. Arzneimittel-Forschung/Drug Research 41: 481–483

    Google Scholar 

  57. Akhtardzhiev K, Kitanov G (1974) Catechin composition of Hypericum perforatum. Farmatsiya 24: 17–20

    Google Scholar 

  58. Gunatilaka AAL, Balasubramaniam S, Kumar V (1979) Studies on medicinal and related plants of Sri-Lanka.1. 2,3-dimethoxyxanthone from Hypericum-mysorense. Phytochemistry 18: 182–183

    Google Scholar 

  59. Suzuki O, Katsumata Y, Oya M, Chari VM, Klapfenberger R, Wagner H, Hostettmann K (1981) Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med 42: 17–21

    PubMed  Google Scholar 

  60. Sparenberg B, Demisch L, Hölzl J (1993) Untersuchungen über antidepressive Wirkstoffe von Johanniskraut. J Pharm Ztg Wiss 6: 50–54

    Google Scholar 

  61. Ollivier B, Balansard G, Maillard C, Vidal E (1985) Separation and identification of phenolic-acids by HPLC and UV spectral-analysis — Application to parietary (Parietaria officinalis L) and to Saint-Johns Wort (Hypericum perforatum L). J Pharm Bel 40: 173–177

    Google Scholar 

  62. Mathis C, Ourisson G (1964) Etude chimio-taxonomique du genre Hypericum II. Identification de constituents de diverses huiles essentielles d’Hypericum. Phytochemistry 3: 115–131

    Google Scholar 

  63. Mathis C, Ourisson G (1964) Etude chimio-taxonomique du genre Hypericum III. Répartition des carbures saturés et des monoterpènes dans les huiles essentielles d’Hypericum. Phytochemistry 3: 133–141

    Google Scholar 

  64. Mathis C, Ourisson G (1964) etude chimio-taxonomique du genre Hypericum IV. Répartition des sesquiterpenes, des alcools monoterpeniques et des aldehydes saturés dans les huiles essentielles d’Hypericum. Phytochemistry 3: 377–378

    Google Scholar 

  65. Schwob I, Bessiere JM, Viano J (2002) Composition of the essential oils of Hypericum perforatum L. from southeastern France. CR Biologies 325: 781–785

    Google Scholar 

  66. Mimica-Dukic N, Ivancev-Tumbas I, Igic R, Popovic M, Gasic O (1997) The content and composition of the essential oil of Hypericum perforatum from Serbia. Pharm Pharmacol Let 8: 26–28

    Google Scholar 

  67. Hölzl J, Ostrowski E (1987) Johanniskraut (Hypericum perforatum L.). HPLC-Analyse der wichtigen Inhaltstoffe und deren Variabilität in einer Population. Dtsch Apoth Ztg 127: 1227–1230

    Google Scholar 

  68. Brondz I, Greibrokk T, Aasen AJ (1983) Normal-alkanes of Hypericum perforatum — a revision. Phytochemistry 22: 295–296

    Google Scholar 

  69. Brondz I, Greibrokk T (1983) N-l-alkanols of Hypericum perforatum. J Nat Prod 46: 940–941

    Google Scholar 

  70. Commission_E_of_the_German_Federal_Public_Health_Departement (1984) Monograph Hyperici herba, Johanniskraut, Berlin

    Google Scholar 

  71. Berghofer R (1987) Dissertation, Universität Marburg

    Google Scholar 

  72. von Eggelklaaut-Gottanka SG, Abu Abed S, Muller W, Schmidt PC (2002) Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John’s Wort). Phytochem Anal 13: 170–176

    PubMed  Google Scholar 

  73. Holz J, Ostrowski E (1987) Dtsch Apoth Ztg 23

    Google Scholar 

  74. Kartnig T, Göbel I (1992) Determination of hypericin and pseudohypericin by thin-layer chromatography-densitometry. J Chromat 609: 423–426

    Google Scholar 

  75. Southwell IA, Campbell MH (1991) Hypericin content variation in Hypericum perforatum in Australia. Phytochemistry 30: 475–478

    Google Scholar 

  76. Brolis M, Gabetta B, Fuzzati N, Pace R, Panzeri F, Peterlongo F (1998) Identification by high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J Chromatogr A 825: 9–16

    Google Scholar 

  77. Poutaraud A, Lobstein A, Girardin P, Weniger B (2001) Improved procedure for the quality control of Hypericum perforatum L. Phytochem Anal 12: 355–362

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Hostettmann, K., Wolfender, JL. (2005). Phytochemistry. In: Müller, W.E. (eds) St. John’s Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7338-5_2

Download citation

Publish with us

Policies and ethics